GANSERT, JENNIFER LORRAINE,MURUGAPPAN, SWAMINATHAN,WOLF, MICHAEL KEVIN
申请号：
CA3075294
公开号：
CA3075294A1
申请日:
2018.10.26
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
Methods and compositions for treating primary hepatic cancers and/or secondary hepatic cancers using a combination of talimogene laherparepvec and pembrolizumab, a pembrolizumab variant or an antigen-binding fragment thereof are provided.
